Jun Kato

10PUBLICATIONS
59CO-AUTHORS
GlycoconjugatesPredictive and prognostic markersPhysical oceanographyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Jan 28, 2026
Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study.

Kazuki Watabe, Motoyasu Kan, Izumi Ohno

|Jul 12, 2024
Clinical outcomes and reintervention after endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis in absence of cholangitis.

Ryosuke Horio, Jun Kato, Takashi Taida

|Feb 13, 2024
Severe ulcerative colitis induced by COVID-19 vaccination.

Takashi Taida, Jun Kato, Kentaro Ishikawa

|Dec 28, 2020
Risk Factors for Acute Cholangitis Caused by Enterococcus faecalis and Enterococcus faecium.

Yuki Karasawa, Jun Kato, Satoshi Kawamura

|Jun 12, 2020
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.

Sakiko Hiraoka, Akiko Fujiwara, Tatsuya Toyokawa

Pageof 2

Frequent Collaborators

3 joint publications

Hideyuki Tamai

1 joint publications

Yasunobu Yamashita

1 joint publications

Koki Kawanishi

1 joint publications

Sakiko Hiraoka